Desq Long
Sign in

This filing amends an original submitted 2025-11-10, which is not in this dataset. View the filer’s history on EDGAR.

SEC FORM 4
$461,906.10

CytomX Therapeutics, Inc. (CTMX)

Sale of 101,793 shares at $4.5377 per share.

Reporting Person McCarthy Sean A. · Officer Title CEO · Transaction Code S

Traded Nov 6, 2025 · Disclosed Oct 16, 2026FILED +344 DAYS

Source: SEC Form 4 · 0001610717-26-000442 · filed 2026-10-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "CytomX Therapeutics, Inc. (CTMX)." Disclosed 2026-10-16. https://desqlong.com/cards/0001610717-26-000442-2 (retrieved 2026-10-17).